Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) Cost of Revenue (2018 - 2025)

Nexgel (NXGL) has disclosed Cost of Revenue for 8 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue fell 5.27% year-over-year to $1.7 million, compared with a TTM value of $6.8 million through Sep 2025, up 31.3%, and an annual FY2024 reading of $5.9 million, up 59.89% over the prior year.
  • Cost of Revenue was $1.7 million for Q3 2025 at Nexgel, up from $1.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.9 million in Q4 2024 and bottomed at $309000.0 in Q1 2021.
  • Average Cost of Revenue over 5 years is $943473.7, with a median of $877000.0 recorded in 2023.
  • The sharpest move saw Cost of Revenue surged 136.64% in 2023, then fell 5.27% in 2025.
  • Year by year, Cost of Revenue stood at $430000.0 in 2021, then rose by 14.88% to $494000.0 in 2022, then soared by 136.64% to $1.2 million in 2023, then surged by 62.7% to $1.9 million in 2024, then fell by 11.09% to $1.7 million in 2025.
  • Business Quant data shows Cost of Revenue for NXGL at $1.7 million in Q3 2025, $1.6 million in Q2 2025, and $1.6 million in Q1 2025.